A Multicenter, Open-Label Study of Sebelipase Alfa in Patients With Lysosomal Acid Lipase Deficiency
Phase of Trial: Phase II
Latest Information Update: 27 May 2019
Price : $35 *
At a glance
- Drugs Sebelipase alfa (Primary)
- Indications Cholesterol ester storage disease; Wolman disease
- Focus Adverse reactions
- Sponsors Alexion Pharmaceuticals; Synageva BioPharma
- 14 Feb 2018 Status changed from active, no longer recruiting to completed.
- 09 Feb 2018 This trial has been completed in Belgium(2017-12-28).
- 26 Jan 2018 This trial has been completed in Denmark (2017-12-28).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History